Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-04SPRY144RICHARD LOWENTHAL plan to sell securities of ARS PHARMACEUTICALS, INC. under Form 144MEDIUM
RICHARD LOWENTHAL filed Form 144 to notify SEC of plan to sell 75000 units of ARS PHARMACEUTICALS, INC. securities around 2026-09-04, with aggregate market value of $421,057.50. The total outstanding units is 99447343.0. The amount planned to be sold represents 0.08% of total outstanding units; Recent transactions in p...
Small CapBiotechnology
2026-09-04ARVN144NOAH C BERKOWITZ plan to sell securities of ARVINAS, INC. under Form 144MEDIUM
NOAH C BERKOWITZ filed Form 144 to notify SEC of plan to sell 8300 units of ARVINAS, INC. securities around 2026-09-04, with aggregate market value of $78,438.32. The total outstanding units is 65386191.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 months in...
Small CapBiotechnology
2026-09-04ALEC144GRACE WONG-SARAD plan to sell securities of ALECTOR, INC. under Form 144MEDIUM
GRACE WONG-SARAD filed Form 144 to notify SEC of plan to sell 3625 units of ALECTOR, INC. securities around 2026-09-04, with aggregate market value of $9,094.40. The total outstanding units is 111656919.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months in...
Micro CapBiotechnology
2026-09-04ARVINAS, INC.144NOAH C BERKOWITZ plan to sell securities of ARVINAS, INC. under Form 144DuplicateMEDIUM
NOAH C BERKOWITZ filed Form 144 to notify SEC of plan to sell 8300 units of ARVINAS, INC. securities around 2026-09-04, with aggregate market value of $78,438.32. The total outstanding units is 65386191.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 months in...
Small CapBiotechnology